|
000
| 01976nam 2200397zi 4500 |
|---|
| 001 | 9.881612 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107170104 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 191104t20202020onca ob f000 0 eng d |
|---|
| 020 | |a9780660331492 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-261/2019E-PDF |
|---|
| 245 | 00|aInterim statement on the use of the rVSVΔG-ZEBOV-GP vaccine for the prevention of Ebola virus disease. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (84 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Déclaration provisoire sur l'utilisation du vaccin rVSVΔG-ZEBOV-GP pour la prévention de la maladie à virus Ebola. |
|---|
| 500 | |aAt head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Publication date: January 2020." |
|---|
| 500 | |a"Pub.: 190428." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 30-34). |
|---|
| 650 | 0|aEbola virus disease|xVaccination|zCanada. |
|---|
| 650 | 0|aRhabdoviruses|xTherapeutic use|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tDéclaration provisoire sur l'utilisation du vaccin rVSVΔG-ZEBOV-GP pour la prévention de la maladie à virus Ebola.|w(CaOODSP)9.881618 |
|---|
| 856 | 40|qPDF|s1.79 MB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/HP40-261-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/interim-statement-vaccine-prevention-ebola-virus-disease.html |
|---|